Prognostic Value of Age-Adjusted D-Dimer Cutoff Thresholds in Patients with Acute Coronary Syndrome Treated by Percutaneous Coronary Intervention

References

• Righini M, Van Es J, Den Exter PL, et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA. 2014;311(11):1117–1124. doi:10.1001/jama.2014.2135
   PubMed Web of Science ®Google Scholar
• Tritschler T, Kraaijpoel N, Le Gal G, Wells PS. Venous thromboembolism: advances in diagnosis and treatment. JAMA. 2018;320(15):1583–1594. doi:10.1001/jama.2018.14346
   PubMed Web of Science ®Google Scholar
• Naruse H, Ishii J, Takahashi H, et al. Prognostic value of combination of plasma D-dimer concentration and estimated glomerular filtration rate in predicting long-term mortality of patients with stable coronary artery disease. Circ J. 2017;81(10):1506–1513. doi:10.1253/circj.CJ-16-1272
   PubMed Web of Science ®Google Scholar
• Simes J, Robledo KP, White HD, et al. D-dimer predicts long-term cause-specific mortality, cardiovascular events, and cancer in patients with stable coronary heart disease. Circulation. 2018;138(7):712–723. doi:10.1161/CIRCULATIONAHA.117.029901
   PubMed Web of Science ®Google Scholar
• Akgul O, Uyarel H, Pusuroglu H, et al. Predictive value of elevated D-dimer in patients undergoing primary angioplasty for ST elevation myocardial infarction. Blood Coagul Fibrinolysis. 2013;24(7):704–710. doi:10.1097/MBC.0b013e3283610396
   PubMed Web of Science ®Google Scholar
• Erkol A, Oduncu V, Turan B, et al. The value of plasma D-dimer level on admission in predicting no-reflow after primary percutaneous coronary intervention and long-term prognosis in patients with acute ST segment elevation myocardial infarction. J Thromb Thrombolys. 2014;38(3):339–347. doi:10.1007/s11239-013-1044-3
   PubMed Web of Science ®Google Scholar
• Kikkert WJ, Claessen BE, Stone GW, et al. D-dimer levels predict ischemic and hemorrhagic outcomes after acute myocardial infarction: a HORIZONS-AMI biomarker substudy. J Thromb Thrombolys. 2014;37(2):155–164. doi:10.1007/s11239-013-0953-5
   PubMed Web of Science ®Google Scholar
• Tello-Montoliu A, Marin F, Roldan V, et al. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels. J Intern Med. 2007;262(6):651–658. doi:10.1111/j.1365-2796.2007.01871.x
   PubMed Web of Science ®Google Scholar
• Sarli B, Akpek M, Baktir AO, et al. Impact of D-dimer level on postinterventional coronary flow and in-hospital MACE in ST-segment elevation myocardial infarction. Herz. 2015;40(3):507–513. doi:10.1007/s00059-013-4029-2
   PubMed Web of Science ®Google Scholar
• Mjelva OR, Ponitz V, Brugger-Andersen T, Grundt H, Staines H, Nilsen DW. Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome. Eur J Prev Cardiol. 2016;23(11):1130–1140. doi:10.1177/2047487315619733
   PubMed Web of Science ®Google Scholar
• Pineda J, Marin F, Marco P, et al. The prognostic value of biomarkers after a premature myocardial infarction. Int J Cardiol. 2010;143(3):249–254. doi:10.1016/j.ijcard.2009.02.019
   PubMed Web of Science ®Google Scholar
• Zhao X, Liu C, Zhou P, et al. Estimation of major adverse cardiovascular events in patients with myocardial infarction undergoing primary percutaneous coronary intervention: a risk prediction score model from a derivation and validation study. Front Cardiovasc Med. 2020;7:603621. doi:10.3389/fcvm.2020.603621
   PubMed Web of Science ®Google Scholar
• Chen R, Liu C, Zhou P, et al. Prognostic value of D-dimer in patients with acute coronary syndrome treated by percutaneous coronary intervention: a retrospective cohort study. Thromb J. 2021;19(1):30. doi:10.1186/s12959-021-00281-y
   PubMed Web of Science ®Google Scholar
• Favaloro EJ, Franchini M, Lippi G. Aging hemostasis: changes to laboratory markers of hemostasis as we age - a narrative review. Semin Thromb Hemost. 2014;40(6):621–633. doi:10.1055/s-0034-1384631
   PubMed Web of Science ®Google Scholar
• Haase C, Joergensen M, Ellervik C, Joergensen MK, Bathum L. Age- and sex-dependent reference intervals for D-dimer: evidence for a marked increase by age. Thromb Res. 2013;132(6):676–680. doi:10.1016/j.thromres.2013.09.033
   PubMed Web of Science ®Google Scholar
• McBane RD 2nd, Hardison RM, Sobel BE. Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the bari 2D trial). Am J Cardiol. 2010;105(1):17–24. doi:10.1016/j.amjcard.2009.08.643
   PubMed Web of Science ®Google Scholar
• van Es N, van der Hulle T, van Es J, et al. Wells rule and D-Dimer testing to rule out pulmonary embolism: a systematic review and individual-patient data meta-analysis. Ann Intern Med. 2016;165(4):253–261. doi:10.7326/M16-0031
   PubMed Web of Science ®Google Scholar
• Douma RA, le Gal G, Sohne M, et al. Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts. BMJ. 2010;340:c1475. doi:10.1136/bmj.c1475
   PubMed Web of Science ®Google Scholar
• Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–177. doi:10.1093/eurheartj/ehx393
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40(3):237–269.
   PubMed Web of Science ®Google Scholar
• Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289–1367. doi:10.1093/eurheartj/ehaa575
   PubMed Web of Science ®Google Scholar
• Newson RB. Comparing the predictive powers of survival models using Harrell’s C or Somers’ D. Stata J. 2010;10(3):339–358. doi:10.1177/1536867X1001000303
   Web of Science ®Google Scholar
• Pencina MJ, D’Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30(1):11–21. doi:10.1002/sim.4085
   PubMed Web of Science ®Google Scholar
• Lunt M. Mark Lunt’s personal home page. Available from: http://personalpagesmanchesteracuk/staff/marklunt/. Accessed January 20, 2020.
   Google Scholar
• Teunissen PFA, Tijssen R, van Montfoort ML, et al. Kinetics of coagulation in ST-elevation myocardial infarction following successful primary percutaneous coronary intervention. Thromb Res. 2016;137:64–71. doi:10.1016/j.thromres.2015.11.017
   PubMed Web of Science ®Google Scholar
• Kyrle PA, Eichinger S. D-dimer for long-term risk prediction in patients after acute coronary syndrome. Circulation. 2018;138(7):724–726. doi:10.1161/CIRCULATIONAHA.118.033670
   PubMed Web of Science ®Google Scholar
• Giannitsis E, Mair J, Christersson C, et al. How to use D-dimer in acute cardiovascular care. Eur Heart J Acute Cardiovasc Care. 2017;6(1):69–80. doi:10.1177/2048872615610870
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang S, Liu J, et al. D-dimer and the incidence of heart failure and mortality after acute myocardial infarction. Heart. 2020;107(3):44–237.
   Web of Science ®Google Scholar
• Malik AH, Yandrapalli S, Shetty SS, Aronow WS, Cooper HA, Panza JA. Meta-analysis of dual antiplatelet therapy versus monotherapy with P2Y12 inhibitors in patients after percutaneous coronary intervention. Am J Cardiol. 2020;127:25–29. doi:10.1016/j.amjcard.2020.04.027
   PubMed Web of Science ®Google Scholar
• Mavrakanas TA, Chatzizisis YS, Gariani K, et al. Duration of dual antiplatelet therapy in patients with CKD and drug-eluting stents: a meta-analysis. Clin J Am Soc Nephrol. 2019;14(6):810–822. doi:10.2215/CJN.12901018
   PubMed Web of Science ®Google Scholar
• Wu Y, Song Y, Pan Y, Gong Y, Zhou Y. Long-term and short-term duration of thienopyridine therapy after coronary stenting in patients with chronic kidney disease a meta-analysis of literature studies. Platelets. 2020;31(4):483–489. doi:10.1080/09537104.2019.1647528
   PubMed Web of Science ®Google Scholar
• Yu T, Jiao Y, Song J, et al. Hospital mortality in acute coronary syndrome: adjustment of GRACE score by D-dimer enables a more accurate prediction in a prospective cohort study. BMC. 2019;19(1):252. doi:10.1186/s12872-019-1239-4
   Web of Science ®Google Scholar
• Pencina MJ, D’Agostino RB, Pencina KM, Janssens AC, Greenland P. Interpreting incremental value of markers added to risk prediction models. Am J Epidemiol. 2012;176(6):473–481. doi:10.1093/aje/kws207
   PubMed Web of Science ®Google Scholar
• Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115(7):928–935. doi:10.1161/CIRCULATIONAHA.106.672402
   PubMed Web of Science ®Google Scholar
• Kothari H, Nguyen AT, Yang X, et al. Association of D-dimer with plaque characteristics and plasma biomarkers of oxidation-specific epitopes in stable subjects with coronary artery disease. J Cardiovasc Transl Res. 2018;11(3):221–229. doi:10.1007/s12265-018-9790-4
   PubMed Web of Science ®Google Scholar
• Corban MT, Hung OY, Mekonnen G, et al. Elevated levels of serum fibrin and fibrinogen degradation products are independent predictors of larger coronary plaques and greater plaque necrotic core. Circ J. 2016;80(4):931–937. doi:10.1253/circj.CJ-15-0768
   PubMed Web of Science ®Google Scholar
• Kumakura H, Fujita K, Kanai H, et al. High-sensitivity c-reactive protein, lipoprotein (a) and homocysteine are risk factors for coronary artery disease in Japanese patients with peripheral arterial disease. J Atheroscler Thromb. 2015;22(4):344–354. doi:10.5551/jat.25478
   PubMed Web of Science ®Google Scholar
• de Maat MP, Bladbjerg EM, Drivsholm T, Borch-Johnsen K, Møller L, Jespersen J. Inflammation, thrombosis and atherosclerosis: results of the Glostrup study. J Thromb Haemost. 2003;1(5):950–957. doi:10.1046/j.1538-7836.2003.00213.x
   PubMed Web of Science ®Google Scholar
• Zhang L, Hailati J, Ma X, et al. Analysis of risk factors for different subtypes of acute coronary syndrome. J Int Med Res. 2021;49(5):3000605211008326.
   Web of Science ®Google Scholar
• Frangogiannis NG. Pathophysiology of myocardial infarction. Compr Physiol. 2015;5(4):1841–1875.
   PubMed Web of Science ®Google Scholar
• Connolly SJ, Eikelboom JW, Bosch J, et al. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet. 2018;391(10117):205–218. doi:10.1016/S0140-6736(17)32458-3
   PubMed Web of Science ®Google Scholar
• Eikelboom J. Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes. Eur Heart J. 2002;23(22):1771–1779. doi:10.1053/euhj.2000.3234
   PubMed Web of Science ®Google Scholar
• Mahé I, Drouet L, Chassany O, et al. D-dimer: a characteristic of the coagulation state of each patient with chronic atrial fibrillation. Thromb Res. 2002;107(1–2):1–6. doi:10.1016/S0049-3848(02)00184-6
   PubMed Web of Science ®Google Scholar
• Tomaniak M, Katagiri Y, Modolo R, et al. Vulnerable plaques and patients: state-of-the-art. Eur Heart J. 2020;41(31):2997–3004. doi:10.1093/eurheartj/ehaa227
   PubMed Web of Science ®Google Scholar
• Stefanadis C, Antoniou CK, Tsiachris D, Pietri P. Coronary atherosclerotic vulnerable plaque: current perspectives. J Am Heart Assoc. 2017;6(3). doi:10.1161/JAHA.117.005543
   PubMed Web of Science ®Google Scholar
• Prisco D, Antonucci E, Fedi S, et al. D-dimer increase after percutaneous transluminal angioplasty and clinical recurrence after primary revascularization in acute myocardial infarction? A pilot study. Clin Exp Med. 2001;1(4):219–224. doi:10.1007/s102380100006
   PubMed Web of Science ®Google Scholar
• Gong X, Lei X, Huang Z, et al. D-dimer level predicts angiographic no-reflow phenomenon after percutaneous coronary intervention within 2–7 days of symptom onset in patients with ST-segment elevation myocardial infarction. J Cardiovasc Transl Res. 2020;14(4):34–728.
   Web of Science ®Google Scholar
• AlKhalfan F, Kerneis M, Nafee T, et al. D-dimer levels and effect of rivaroxaban on those levels and outcomes in patients with acute coronary syndrome (an ATLAS ACS-TIMI 46 trial substudy). Am J Cardiol. 2018;122(9):1459–1464. doi:10.1016/j.amjcard.2018.07.032
   PubMed Web of Science ®Google Scholar